Company Profiles

driven by the PitchBook Platform

Aravax

Description

Developer of a vaccine to treat peanut allergies. The company engages in the development of a vaccine which resets the immune system to tolerate peanuts without evoking allergic reactions.

2014

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$4.85M

Latest Deal Amount

$4.85M

Total Amount Raised

Description

Developer of a vaccine to treat peanut allergies. The company engages in the development of a vaccine which resets the immune system to tolerate peanuts without evoking allergic reactions.

Website:

www.aravax.com.au

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

Level 9, 278 Collins Street Melbourne, Victoria 3000Australia +61 (0)3 9657 0700
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aravax's full profile, request a free trial.

    Aravax Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aravax Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Brandon Capital PartnersVenture CapitalMinority000 0000000 0000
    Brandon Capital Partners Venture Capital

    Aravax Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Sara Prickett Ph.DChief Operating Officer & Co-Founder
    Robyn O'HehirChief Scientific Officer & Co-Founder
    Sara Prickett Ph.D Chief Operating Officer & Co-Founder
    Robyn O'Hehir Chief Scientific Officer & Co-Founder

    Aravax Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Christopher SmithBrandon Capital PartnersInvestment Manager000 0000
    Fiona MilesAravaxBoard Member000 0000
    Christopher Smith Investment Manager Brandon Capital Partners
    Fiona Miles Board Member Aravax
    Request full access to PitchBook